ScoreWhy is Gland Pharma Ltd ?
1
The company is Net-Debt Free
2
The company has declared Positive results for the last 3 consecutive quarters
- ROCE(HY) Highest at 14.30%
- NET SALES(Q) Highest at Rs 1,800.27 cr
- PBT LESS OI(Q) At Rs 373.75 cr has Grown at 27.5% (vs previous 4Q average)
3
High Institutional Holdings at 39.18%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
- Along with generating 45.50% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Gland Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Gland Pharma for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Gland Pharma
45.5%
1.37
33.29%
Sensex
-9.4%
-0.70
13.49%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.50%
EBIT Growth (5y)
1.45%
EBIT to Interest (avg)
84.05
Debt to EBITDA (avg)
0.15
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.58
Tax Ratio
28.86%
Dividend Payout Ratio
42.46%
Pledged Shares
0
Institutional Holding
39.18%
ROCE (avg)
20.24%
ROE (avg)
10.76%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
42
Industry P/E
37
Price to Book Value
4.66
EV to EBIT
34.33
EV to EBITDA
25.83
EV to Capital Employed
6.21
EV to Sales
6.72
PEG Ratio
0.87
Dividend Yield
0.68%
ROCE (Latest)
16.56%
ROE (Latest)
10.09%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
ROCE(HY)
Highest at 14.30%
NET SALES(Q)
Highest at Rs 1,800.27 cr
PBT LESS OI(Q)
At Rs 373.75 cr has Grown at 27.5% (vs previous 4Q average
PAT(Q)
At Rs 316.96 cr has Grown at 21.3% (vs previous 4Q average
-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.40 times
Loading Valuation Snapshot...
Here's what is working for Gland Pharma
Net Sales - Quarterly
Highest at Rs 1,800.27 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 373.75 cr has Grown at 27.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 293.15 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 316.96 cr has Grown at 21.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 261.23 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Gland Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 3.40 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
